WHO joins clamor to make new hepatitis C pills affordable
LONDON (Reuters) - The World Health Organization wants a "concerted effort" to drive down the cost of new hepatitis C drugs that offer a cure for the liver-destroying virus but...
All Stories
Gilead aims to license hepatitis C drug to 3-4 Indian firms
LONDON (Reuters) - Gilead Sciences aims to license its new hepatitis C drug Sovaldi to three or four Indian generic manufacturers to allow sales of the medicine at lower prices...
Gilead aims to license hepatitis C drug to 3-4 Indian firms
LONDON (Reuters) - Gilead Sciences aims to license its new hepatitis C drug Sovaldi to three or four Indian generic manufacturers to allow sales of the medicine at lower prices...
Drugmaker GSK to invest $200 million in African factories, R&D
(Reuters) - Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds ($216 million) in Africa over the next five years as chronic diseases become more common among the continent's...
Drugmaker GSK to invest $200 million in African factories, R&D
(Reuters) - Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds ($216 million) in Africa over the next five years as chronic diseases become more common among the continent's...
AstraZeneca digs into new Cambridge home with MRC drug deal
CAMBRIDGE, England (Reuters) - AstraZeneca, which will complete its move to Cambridge by 2016, is already putting down roots in the ecosystem of the university city as it seeks to...
AstraZeneca digs into new Cambridge home with MRC drug deal
CAMBRIDGE, England (Reuters) - AstraZeneca, which will complete its move to Cambridge by 2016, is already putting down roots in the ecosystem of the university city as it seeks to...
British cost agency to take broader view of drug value
LONDON (Reuters) - British healthcare cost agency NICE is to take a broader view of the value offered by new medicines under proposals that may make it more likely that...
GSK links with top labs on ‘big data’ drug project
LONDON (Reuters) - GlaxoSmithKline is linking with two top bioscience centres on an open-access research project to tap into "big data" generated by gene research, in a move highlighting how...
GSK links with top labs on ‘big data’ drug project
LONDON (Reuters) - GlaxoSmithKline is linking with two top bioscience centres on an open-access research project to tap into "big data" generated by gene research, in a move highlighting how...